News and Events | Preventogen

Preventogen is now easy to purchase! Call 833-330-ARCG (2724) Email [email protected]

Press release

Prevent-Plus announces the full US commercial launch of PREVENTOGEN in partnership with ARC Group Medical

Arch Grants class of 2021

Press release

St. Louis Based Biotech Start-up Prevent-Plus Recognized as a 2021 Arch Grants Recipient

Clinical study

New clinical data highlighting the clinical success and efficacy of Preventogen

Clinical article

A Closer Look At An Emerging Option To Reduce Post-Op Infections

Clinical article

Prevention is the key—75,000 infection-related deaths and $33 Billion in costs

Press release

Preventogen: One of the first FDA-cleared products shown to reliably kill urgent CDC threat Candida auris in a lab

TRAINING

Preventogen is a product of Prevent-Plus, LLC © 2022 Prevent-Plus, LLC. All rights reserved.

Privacy Policy | Terms of Service | Accessibility Statement